Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
about
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Similar and different gray matter deficits in schizophrenia patients and their unaffected biological relativesUltrastructural localization of tyrosine hydroxylase in tree shrew nucleus accumbens core and shell.Assessment of cytochrome C oxidase dysfunction in the substantia nigra/ventral tegmental area in schizophrenia.Pathway-Specific Dopamine Abnormalities in Schizophrenia.Functional connectivity density alterations in schizophrenia.Impaired working memory capacity is not caused by failures of selective attention in schizophrenia.Neurochemical characterization of the tree shrew dorsal striatumNeuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.Immunohistochemical localization of enkephalin in the human striatum: a postmortem ultrastructural studyRhes: a GTP-binding protein integral to striatal physiology and pathology.Does baseline cerebral blood flow affect task-related blood oxygenation level dependent response in schizophrenia?Abnormal Degree Centrality of Bilateral Putamen and Left Superior Frontal Gyrus in Schizophrenia with Auditory Hallucinations: A Resting-state Functional Magnetic Resonance Imaging Study.Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseasesProton magnetic resonance spectroscopy of the substantia nigra in schizophreniaA phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brainVentral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis.What neurophysiological recordings tell us about cognitive and behavioral functions of the human subthalamic nucleus.Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.Current Concepts on the Physiopathological Relevance of Dopaminergic ReceptorsProtein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.An accurate method for the quantification of cytochrome C oxidase in tissue sections.Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorder: A Possible Link to Dopamine Dysfunction?Extrapyramidal examinations in psychiatry.Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis.Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling.Decreased Left Putamen and Thalamus Volume Correlates with Delusions in First-Episode Schizophrenia Patients.Altered Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Schizophrenia.Mitochondria in the striatum of subjects with schizophrenia.Vulnerability of the mesencephalic dopaminergic neurons of the human neonate to prolonged perinatal hypoxia: an immunohistochemical study of tyrosine hydroxylase expression in autopsy material.Motor system dysfunction in the schizophrenia diathesis: Neural systems to neurotransmitters.TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease.Medium spiny neurons of the neostriatal matrix exhibit specific, stereotyped changes in dendritic arborization during a critical developmental period in mice.Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia.
P2860
Q30437188-C8BFB0CF-F3E8-4E20-98A3-D6DFF760175AQ30711211-8AB18A86-E0CD-42B6-97A0-EBC3C7957390Q33766611-082CB999-087D-4B7B-A385-0F9025E160E7Q33773639-2B887B6D-643E-4C18-AC91-0F03F91CF4C5Q34527656-25DF5A23-8F93-4ABF-BB79-54D2E8FE2306Q34541037-669F71CE-7400-4FCA-9846-04438D3D8CFAQ35096544-A73787D9-0D5B-422F-8057-5B3AC53E9CE3Q35167455-4D181297-6292-44C0-9A9A-ACD37E105862Q35285315-901D034D-6058-4BD1-ABFF-1CD1D79F21FDQ35858750-4AA85B3B-06CF-4ADD-8693-C181A458C583Q35875941-40DDD6FF-7C77-4469-8D64-BA495BBC79D2Q35989560-ACE1741A-DC0C-4EE5-BA70-1423F2408DC2Q36095030-B0897830-C143-4668-BDFD-C968169FE2A5Q36177033-5E1516BA-D480-4A98-A7D5-A6A755EC6406Q36694683-AE1298FA-5349-4692-B048-EAE1D2B64355Q37140821-4748DD1E-6A6D-4831-B053-B114B55F1BD0Q37141400-BAC9D972-A12B-45D2-AEF0-29173652CBBCQ37338780-BB5297A0-316C-4B88-A057-616AF4DBE4EEQ37390685-BB8B4455-21C4-423C-AC23-20E95B559E44Q37560665-E55BE249-EE7E-4DB1-8DD6-EF8160750EB1Q37584279-86C079B2-C07A-4F1B-A114-C4CF994F7A04Q37624223-9EAB8F32-70EB-4706-819C-8461105EBE19Q37820993-67FB8C4F-3E20-4FDB-B1D2-A103F54CE7C6Q38770356-E9A98D46-2AE1-4B2C-855E-EAB7D409FD6BQ39147170-7B5DDD11-35A2-444A-AF88-BC57731E457CQ39464596-A5015C1C-0793-4142-ABD8-0E59B6A3580AQ40391409-F98565A3-3306-4D35-B2D0-39AF07E82050Q40493223-27DCC8AD-AF8B-4C33-80FB-3808796B3F1BQ41819903-96DA5D2C-2B9E-4AF0-A7D8-AFFC7665693AQ41850803-7579445B-673B-40A9-B9DB-ABE8A7C4C838Q42521116-F7E1BE82-76DD-4063-BA81-625AA21A779EQ47142790-9A0850D4-BAA3-46C1-B6E3-E4385C3352A2Q47719299-7E075571-59FE-403C-8226-2CE2386F33DEQ48094326-411F3780-861E-43D6-9699-4AF6E1A8AB7EQ48130399-59627423-7BCA-4380-990C-0B5005B1B90EQ48228571-13E9F251-329A-49BD-84CB-995596E1CA5DQ48272772-EA5918A2-CAD1-42D3-8698-14E191971D1EQ48654934-0BB26031-3A8E-4FA3-AA11-D1E8E5F4B964Q48843841-BB7CA777-EBEA-4EE5-9D34-E2CAB35EFF0DQ48908767-A05863DD-FCAD-4B9F-9651-34D4C3CA9EB4
P2860
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@en
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@nl
type
label
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@en
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@nl
prefLabel
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@en
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.
@nl
P2860
P921
P1476
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies
@en
P2093
Miguel Melendez-Ferro
Rosalinda C Roberts
P2860
P304
P356
10.1111/J.1471-4159.2010.06604.X
P407
P577
2010-01-20T00:00:00Z